| Symbol |
Name |
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACVR1
|
activin A receptor, type I
|
|
ADAMTS12
|
ADAM metallopeptidase with thrombospondin type 1 motif, 12
|
|
ADM
|
adrenomedullin
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALPP
|
alkaline phosphatase, placental
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
APC
|
adenomatous polyposis coli
|
|
APLN
|
apelin
|
|
APLNR
|
apelin receptor
|
|
APOA4
|
apolipoprotein A-IV
|
|
APOD
|
apolipoprotein D
|
|
AR
|
androgen receptor
|
|
ARNTL2
|
aryl hydrocarbon receptor nuclear translocator-like 2
|
|
ARRB1
|
arrestin, beta 1
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP6AP2
|
ATPase, H+ transporting, lysosomal accessory protein 2
|
|
ATPIF1
|
ATPase inhibitory factor 1
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRE
|
brain and reproductive organ-expressed (TNFRSF1A modulator)
|
|
BSG
|
basigin (Ok blood group)
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
CA9
|
carbonic anhydrase IX
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPRIN2
|
caprin family member 2
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCDC88A
|
coiled-coil domain containing 88A
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCND3
|
cyclin D3
|
|
CCNH
|
cyclin H
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CD19
|
CD19 molecule
|
|
CD1D
|
CD1d molecule
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD320
|
CD320 molecule
|
|
CD34
|
CD34 molecule
|
|
CD38
|
CD38 molecule
|
|
CD4
|
CD4 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD80
|
CD80 molecule
|
|
CD86
|
CD86 molecule
|
|
CD8A
|
CD8a molecule
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC6
|
cell division cycle 6
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2AIP
|
CDKN2A interacting protein
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CENPF
|
centromere protein F, 350/400kDa
|
|
CFH
|
complement factor H
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CLDN18
|
claudin 18
|
|
CLEC11A
|
C-type lectin domain family 11, member A
|
|
CLU
|
clusterin
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COL16A1
|
collagen, type XVI, alpha 1
|
|
CORT
|
cortistatin
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREG1
|
cellular repressor of E1A-stimulated genes 1
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CST3
|
cystatin C
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CTSG
|
cathepsin G
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A7
|
cytochrome P450, family 3, subfamily A, polypeptide 7
|
|
DAZ1
|
deleted in azoospermia 1
|
|
DBF4
|
DBF4 zinc finger
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDX4
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F3
|
E2F transcription factor 3
|
|
EDN1
|
endothelin 1
|
|
EDNRB
|
endothelin receptor type B
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ENG
|
endoglin
|
|
ENO1
|
enolase 1, (alpha)
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EP400
|
E1A binding protein p400
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA4
|
EPH receptor A4
|
|
EPO
|
erythropoietin
|
|
EPS15
|
epidermal growth factor receptor pathway substrate 15
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ERP29
|
endoplasmic reticulum protein 29
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBLN5
|
fibulin 5
|
|
FCN3
|
ficolin (collagen/fibrinogen domain containing) 3
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FKBPL
|
FK506 binding protein like
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FXYD3
|
FXYD domain containing ion transport regulator 3
|
|
FZD2
|
frizzled class receptor 2
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA3
|
GATA binding protein 3
|
|
GATA6
|
GATA binding protein 6
|
|
GCG
|
glucagon
|
|
GDF2
|
growth differentiation factor 2
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GLE1
|
GLE1 RNA export mediator
|
|
GLP2R
|
glucagon-like peptide 2 receptor
|
|
GLRX2
|
glutaredoxin 2
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GNRH2
|
gonadotropin-releasing hormone 2
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
H2AFX
|
H2A histone family, member X
|
|
HAS1
|
hyaluronan synthase 1
|
|
HAS2
|
hyaluronan synthase 2
|
|
HAS3
|
hyaluronan synthase 3
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HDAC1
|
histone deacetylase 1
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HES6
|
hes family bHLH transcription factor 6
|
|
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HJURP
|
Holliday junction recognition protein
|
|
HK2
|
hexokinase 2
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HP
|
haptoglobin
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB8
|
heat shock 22kDa protein 8
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNA8
|
interferon, alpha 8
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
IL10
|
interleukin 10
|
|
IL11
|
interleukin 11
|
|
IL12B
|
interleukin 12B
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RAP
|
interleukin 1 receptor accessory protein
|
|
IL2
|
interleukin 2
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INSR
|
insulin receptor
|
|
IPO13
|
importin 13
|
|
IRF3
|
interferon regulatory factor 3
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ12
|
potassium channel, inwardly rectifying subfamily J, member 12
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KDM5B
|
lysine (K)-specific demethylase 5B
|
|
KDR
|
kinase insert domain receptor
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1
|
|
KNG1
|
kininogen 1
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LAMP2
|
lysosomal-associated membrane protein 2
|
|
LCN2
|
lipocalin 2
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LIF
|
leukemia inhibitory factor
|
|
LMO4
|
LIM domain only 4
|
|
LOX
|
lysyl oxidase
|
|
LTA
|
lymphotoxin alpha
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAST1
|
microtubule associated serine/threonine kinase 1
|
|
MAST2
|
microtubule associated serine/threonine kinase 2
|
|
MAT2A
|
methionine adenosyltransferase II, alpha
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MEGF10
|
multiple EGF-like-domains 10
|
|
MEIS1
|
Meis homeobox 1
|
|
MFN2
|
mitofusin 2
|
|
MID1
|
midline 1
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR135B
|
microRNA 135b
|
|
MIR142
|
microRNA 142
|
|
MIR155
|
microRNA 155
|
|
MIR184
|
microRNA 184
|
|
MIR203A
|
microRNA 203a
|
|
MIR218-1
|
microRNA 218-1
|
|
MIR23A
|
microRNA 23a
|
|
MIR23B
|
microRNA 23b
|
|
MIR34A
|
microRNA 34a
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLANA
|
melan-A
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSH2
|
mutS homolog 2
|
|
MSI1
|
musashi RNA-binding protein 1
|
|
MTDH
|
metadherin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTUS1
|
microtubule associated tumor suppressor 1
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUM1
|
melanoma associated antigen (mutated) 1
|
|
MUTYH
|
mutY homolog
|
|
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH10
|
myosin, heavy chain 10, non-muscle
|
|
MYLK
|
myosin light chain kinase
|
|
MYOG
|
myogenin (myogenic factor 4)
|
|
NAPEPLD
|
N-acyl phosphatidylethanolamine phospholipase D
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2E1
|
nuclear receptor subfamily 2, group E, member 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRP2
|
neuropilin 2
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
OTX1
|
orthodenticle homeobox 1
|
|
OTX2
|
orthodenticle homeobox 2
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
OXTR
|
oxytocin receptor
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY8
|
purinergic receptor P2Y, G-protein coupled, 8
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX6
|
paired box 6
|
|
PBK
|
PDZ binding kinase
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD1
|
programmed cell death 1
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDLIM1
|
PDZ and LIM domain 1
|
|
PDS5B
|
PDS5 cohesin associated factor B
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PF4
|
platelet factor 4
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PHGDH
|
phosphoglycerate dehydrogenase
|
|
PHLPP2
|
PH domain and leucine rich repeat protein phosphatase 2
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLD2
|
phospholipase D2
|
|
PLK1
|
polo-like kinase 1
|
|
PLXDC1
|
plexin domain containing 1
|
|
PMEL
|
premelanosome protein
|
|
PML
|
promyelocytic leukemia
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POU3F2
|
POU class 3 homeobox 2
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1R9B
|
protein phosphatase 1, regulatory subunit 9B
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PPRC1
|
peroxisome proliferator-activated receptor gamma, coactivator-related 1
|
|
PRDX4
|
peroxiredoxin 4
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKD3
|
protein kinase D3
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRL
|
prolactin
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PROM1
|
prominin 1
|
|
PROX1
|
prospero homeobox 1
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
RAB31
|
RAB31, member RAS oncogene family
|
|
RABEP2
|
rabaptin, RAB GTPase binding effector protein 2
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RB1
|
retinoblastoma 1
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBM6
|
RNA binding motif protein 6
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
REG3A
|
regenerating islet-derived 3 alpha
|
|
RIN1
|
Ras and Rab interactor 1
|
|
RND3
|
Rho family GTPase 3
|
|
ROBO4
|
roundabout, axon guidance receptor, homolog 4 (Drosophila)
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RPS19
|
ribosomal protein S19
|
|
RPS24
|
ribosomal protein S24
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RSPO1
|
R-spondin 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX3
|
runt-related transcription factor 3
|
|
S100A4
|
S100 calcium binding protein A4
|
|
SDC1
|
syndecan 1
|
|
SELE
|
selectin E
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SEPT11
|
septin 11
|
|
SEPT5
|
septin 5
|
|
SEPT8
|
septin 8
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SFN
|
stratifin
|
|
SHH
|
sonic hedgehog
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC16A4
|
solute carrier family 16, member 4
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SORD
|
sorbitol dehydrogenase
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX5
|
SRY (sex determining region Y)-box 5
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SP7
|
Sp7 transcription factor
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRR1B
|
small proline-rich protein 1B
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SST
|
somatostatin
|
|
SSTR2
|
somatostatin receptor 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK17A
|
serine/threonine kinase 17a
|
|
STMN1
|
stathmin 1
|
|
TAC1
|
tachykinin, precursor 1
|
|
TBX21
|
T-box 21
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCOF1
|
Treacher Collins-Franceschetti syndrome 1
|
|
TERT
|
telomerase reverse transcriptase
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
THBS2
|
thrombospondin 2
|
|
THPO
|
thrombopoietin
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPBG
|
trophoblast glycoprotein
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TPT1
|
tumor protein, translationally-controlled 1
|
|
TRA
|
T cell receptor alpha locus
|
|
TRG
|
T cell receptor gamma locus
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSPO
|
translocator protein (18kDa)
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
TTR
|
transthyretin
|
|
UGT8
|
UDP glycosyltransferase 8
|
|
USP11
|
ubiquitin specific peptidase 11
|
|
USP2
|
ubiquitin specific peptidase 2
|
|
USP7
|
ubiquitin specific peptidase 7 (herpes virus-associated)
|
|
VASH1
|
vasohibin 1
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VSIG4
|
V-set and immunoglobulin domain containing 4
|
|
VSNL1
|
visinin-like 1
|
|
VWA5A
|
von Willebrand factor A domain containing 5A
|
|
VWF
|
von Willebrand factor
|
|
WASF1
|
WAS protein family, member 1
|
|
WNT9A
|
wingless-type MMTV integration site family, member 9A
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
YY1AP1
|
YY1 associated protein 1
|
|
ZBTB32
|
zinc finger and BTB domain containing 32
|
